Mr. Seghezzi is the Managing Partner of Sofinnova Partners, which he joined in 2006. He seeded and served on the Boards of several companies which were successfully sold or went public on Nasdaq.
Mr. Seghezzi has invested in and currently sits on the Boards of Crescendo Biologics, Corvidia Therapeutics, Hookipa Biotech, Inotrem, S.A., and Mission Therapeutics. He started his venture capital career in 2001 at Sofinnova Partners and later joined Index Ventures in Geneva in 2003. Prior, Mr. Seghezzi spent five years working in academic research at the New York University School of Medicine. He holds a degree in Genetics and Microbiology from the University of Pavia, Italy and earned his MBA from RSM Erasmus University, the Netherlands.